Tanaka, R., Watanabe, H., Kodama, A., Chuang, V., Ishima, Y., Hamasaki, K., . . . Maruyama, T. (2013). Long-acting human serum albumin-thioredoxin fusion protein suppresses bleomycin-induced pulmonary fibrosis progression. American Society for Pharmacology and Experimental Therapeutics.
Chicago Style (17th ed.) CitationTanaka, R., et al. Long-acting Human Serum Albumin-thioredoxin Fusion Protein Suppresses Bleomycin-induced Pulmonary Fibrosis Progression. American Society for Pharmacology and Experimental Therapeutics, 2013.
MLA (9th ed.) CitationTanaka, R., et al. Long-acting Human Serum Albumin-thioredoxin Fusion Protein Suppresses Bleomycin-induced Pulmonary Fibrosis Progression. American Society for Pharmacology and Experimental Therapeutics, 2013.
Warning: These citations may not always be 100% accurate.